James C. Edgemond's most recent trade in United Therapeutics Corp was a trade of 8,750 Stock Option done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2026 | 8,750 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 22 Jun 2026 | 8,750 | 27,626 (0%) | 0% | 146.0 | 1,277,763 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 538.23 per share. | 22 Jun 2026 | 2,266 | 22,400 (0%) | 0% | 538.2 | 1,219,638 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 539.13 per share. | 22 Jun 2026 | 1,994 | 20,406 (0%) | 0% | 539.1 | 1,075,025 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 541.25 per share. | 22 Jun 2026 | 1,250 | 18,876 (0%) | 0% | 541.3 | 676,563 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 536.05 per share. | 22 Jun 2026 | 1,091 | 25,506 (0%) | 0% | 536.0 | 584,827 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 534.98 per share. | 22 Jun 2026 | 865 | 26,597 (0%) | 0% | 535.0 | 462,762 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 537.18 per share. | 22 Jun 2026 | 840 | 24,666 (0%) | 0% | 537.2 | 451,234 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 539.82 per share. | 22 Jun 2026 | 280 | 20,126 (0%) | 0% | 539.8 | 151,151 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 534.06 per share. | 22 Jun 2026 | 164 | 27,462 (0%) | 0% | 534.1 | 87,586 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 18 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 146.0 | 1,460,300 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 10,000 | 8,750 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 540.22 per share. | 18 Jun 2026 | 2,978 | 21,053 (0%) | 0% | 540.2 | 1,608,768 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 539.42 per share. | 18 Jun 2026 | 2,035 | 24,031 (0%) | 0% | 539.4 | 1,097,714 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 538.31 per share. | 18 Jun 2026 | 1,440 | 26,066 (0%) | 0% | 538.3 | 775,163 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 541.06 per share. | 18 Jun 2026 | 865 | 20,188 (0%) | 0% | 541.1 | 468,015 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 548.90 per share. | 18 Jun 2026 | 660 | 18,876 (0%) | 0% | 548.9 | 362,275 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 537.24 per share. | 18 Jun 2026 | 600 | 27,506 (0%) | 0% | 537.2 | 322,344 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 533.59 per share. | 18 Jun 2026 | 400 | 28,476 (0%) | 0% | 533.6 | 213,435 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.37 per share. | 18 Jun 2026 | 265 | 19,651 (0%) | 0% | 547.4 | 145,053 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 536.27 per share. | 18 Jun 2026 | 210 | 28,106 (0%) | 0% | 536.3 | 112,617 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 541.89 per share. | 18 Jun 2026 | 192 | 19,996 (0%) | 0% | 541.9 | 104,042 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 534.48 per share. | 18 Jun 2026 | 160 | 28,316 (0%) | 0% | 534.5 | 85,516 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.81 per share. | 18 Jun 2026 | 115 | 19,536 (0%) | 0% | 547.8 | 62,998 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 545.20 per share. | 18 Jun 2026 | 40 | 19,916 (0%) | 0% | 545.2 | 21,808 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 543.52 per share. | 18 Jun 2026 | 40 | 19,956 (0%) | 0% | 543.5 | 21,741 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 10,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 15 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.89 per share. | 15 Jun 2026 | 2,200 | 21,396 (0%) | 0% | 550.9 | 1,211,960 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 548.64 per share. | 15 Jun 2026 | 1,616 | 24,396 (0%) | 0% | 548.6 | 886,601 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 551.91 per share. | 15 Jun 2026 | 1,144 | 20,252 (0%) | 0% | 551.9 | 631,382 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 545.63 per share. | 15 Jun 2026 | 855 | 26,981 (0%) | 0% | 545.6 | 466,517 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 549.87 per share. | 15 Jun 2026 | 800 | 23,596 (0%) | 0% | 549.9 | 439,896 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 553.10 per share. | 15 Jun 2026 | 778 | 19,474 (0%) | 0% | 553.1 | 430,311 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 553.76 per share. | 15 Jun 2026 | 598 | 18,876 (0%) | 0% | 553.8 | 331,150 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 543.51 per share. | 15 Jun 2026 | 560 | 27,836 (0%) | 0% | 543.5 | 304,363 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 546.54 per share. | 15 Jun 2026 | 504 | 26,477 (0%) | 0% | 546.5 | 275,454 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.77 per share. | 15 Jun 2026 | 465 | 26,012 (0%) | 0% | 547.8 | 254,711 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 541.61 per share. | 15 Jun 2026 | 240 | 28,396 (0%) | 0% | 541.6 | 129,987 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 538.52 per share. | 15 Jun 2026 | 121 | 28,755 (0%) | 0% | 538.5 | 65,161 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 539.46 per share. | 15 Jun 2026 | 74 | 28,681 (0%) | 0% | 539.5 | 39,920 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 540.64 per share. | 15 Jun 2026 | 45 | 28,636 (0%) | 0% | 540.6 | 24,329 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 11 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 10,000 | 10,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.04 per share. | 11 Jun 2026 | 3,333 | 20,756 (0%) | 0% | 550.0 | 1,833,283 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 548.02 per share. | 11 Jun 2026 | 2,037 | 26,063 (0%) | 0% | 548.0 | 1,116,312 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 549.11 per share. | 11 Jun 2026 | 1,974 | 24,089 (0%) | 0% | 549.1 | 1,083,934 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 551.10 per share. | 11 Jun 2026 | 1,560 | 19,196 (0%) | 0% | 551.1 | 859,712 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 545.14 per share. | 11 Jun 2026 | 442 | 28,234 (0%) | 0% | 545.1 | 240,951 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 551.82 per share. | 11 Jun 2026 | 320 | 18,876 (0%) | 0% | 551.8 | 176,584 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 544.37 per share. | 11 Jun 2026 | 154 | 28,676 (0%) | 0% | 544.4 | 83,833 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.08 per share. | 11 Jun 2026 | 134 | 28,100 (0%) | 0% | 547.1 | 73,309 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 542.93 per share. | 11 Jun 2026 | 46 | 28,830 (0%) | 0% | 542.9 | 24,975 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 10,000 | 20,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 08 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.91 per share. | 08 Jun 2026 | 2,158 | 21,276 (0%) | 0% | 547.9 | 1,182,392 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 546.13 per share. | 08 Jun 2026 | 1,989 | 25,322 (0%) | 0% | 546.1 | 1,086,260 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.03 per share. | 08 Jun 2026 | 1,888 | 23,434 (0%) | 0% | 547.0 | 1,032,791 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 544.93 per share. | 08 Jun 2026 | 1,565 | 27,311 (0%) | 0% | 544.9 | 852,821 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.09 per share. | 08 Jun 2026 | 1,285 | 19,566 (0%) | 0% | 550.1 | 706,870 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 551.28 per share. | 08 Jun 2026 | 610 | 18,956 (0%) | 0% | 551.3 | 336,282 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 549.38 per share. | 08 Jun 2026 | 425 | 20,851 (0%) | 0% | 549.4 | 233,487 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 551.75 per share. | 08 Jun 2026 | 80 | 18,876 (0%) | 0% | 551.8 | 44,140 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 04 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 10,000 | 30,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 548.04 per share. | 04 Jun 2026 | 2,749 | 20,294 (0%) | 0% | 548.0 | 1,506,555 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 544.94 per share. | 04 Jun 2026 | 1,545 | 25,205 (0%) | 0% | 544.9 | 841,939 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 549.06 per share. | 04 Jun 2026 | 1,298 | 18,996 (0%) | 0% | 549.1 | 712,678 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 545.89 per share. | 04 Jun 2026 | 1,129 | 24,076 (0%) | 0% | 545.9 | 616,308 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 544.11 per share. | 04 Jun 2026 | 1,086 | 26,750 (0%) | 0% | 544.1 | 590,906 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.00 per share. | 04 Jun 2026 | 1,033 | 23,043 (0%) | 0% | 547.0 | 565,055 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 541.14 per share. | 04 Jun 2026 | 480 | 28,276 (0%) | 0% | 541.1 | 259,749 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 542.78 per share. | 04 Jun 2026 | 440 | 27,836 (0%) | 0% | 542.8 | 238,822 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 539.64 per share. | 04 Jun 2026 | 120 | 28,756 (0%) | 0% | 539.6 | 64,757 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.48 per share. | 04 Jun 2026 | 120 | 18,876 (0%) | 0% | 550.5 | 66,057 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 10,000 | 40,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 01 Jun 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 546.23 per share. | 01 Jun 2026 | 2,520 | 24,916 (0%) | 0% | 546.2 | 1,376,488 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 548.26 per share. | 01 Jun 2026 | 1,606 | 21,956 (0%) | 0% | 548.3 | 880,512 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 544.96 per share. | 01 Jun 2026 | 1,440 | 27,436 (0%) | 0% | 545.0 | 784,742 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 547.11 per share. | 01 Jun 2026 | 1,354 | 23,562 (0%) | 0% | 547.1 | 740,789 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 549.30 per share. | 01 Jun 2026 | 1,185 | 20,771 (0%) | 0% | 549.3 | 650,917 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.20 per share. | 01 Jun 2026 | 1,015 | 19,756 (0%) | 0% | 550.2 | 558,448 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 554.47 per share. | 01 Jun 2026 | 400 | 18,876 (0%) | 0% | 554.5 | 221,788 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 552.91 per share. | 01 Jun 2026 | 280 | 19,276 (0%) | 0% | 552.9 | 154,816 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 550.81 per share. | 01 Jun 2026 | 200 | 19,556 (0%) | 0% | 550.8 | 110,162 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 10,000 | 50,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 28 May 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 562.77 per share. | 28 May 2026 | 1,961 | 26,595 (0%) | 0% | 562.8 | 1,103,587 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 563.87 per share. | 28 May 2026 | 1,675 | 24,920 (0%) | 0% | 563.9 | 944,489 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 567.91 per share. | 28 May 2026 | 1,605 | 20,280 (0%) | 0% | 567.9 | 911,502 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 564.82 per share. | 28 May 2026 | 1,208 | 23,712 (0%) | 0% | 564.8 | 682,303 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 566.87 per share. | 28 May 2026 | 934 | 21,885 (0%) | 0% | 566.9 | 529,453 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 566.00 per share. | 28 May 2026 | 893 | 22,819 (0%) | 0% | 566.0 | 505,434 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 568.90 per share. | 28 May 2026 | 844 | 19,436 (0%) | 0% | 568.9 | 480,152 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 570.50 per share. | 28 May 2026 | 332 | 19,104 (0%) | 0% | 570.5 | 189,405 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 561.48 per share. | 28 May 2026 | 320 | 28,556 (0%) | 0% | 561.5 | 179,674 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 571.48 per share. | 28 May 2026 | 228 | 18,876 (0%) | 0% | 571.5 | 130,298 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 10,000 | 60,000 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 26 May 2026 | 10,000 | 28,876 (0%) | 0% | 117.8 | 1,177,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 577.13 per share. | 26 May 2026 | 1,929 | 19,636 (0%) | 0% | 577.1 | 1,113,284 | Common Stock |